These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27603789)

  • 1. P2Y
    Kim CH; Hwang G; Kwon OK; Ban SP; Chinh ND; Tjahjadi M; Oh CW; Bang JS; Kim T
    Radiology; 2017 Feb; 282(2):542-551. PubMed ID: 27603789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard vs Modified Antiplatelet Preparation for Preventing Thromboembolic Events in Patients With High On-Treatment Platelet Reactivity Undergoing Coil Embolization for an Unruptured Intracranial Aneurysm: A Randomized Clinical Trial.
    Hwang G; Huh W; Lee JS; Villavicencio JB; Villamor RB; Ahn SY; Kim J; Chang JY; Park SJ; Park NM; Jeong EA; Kwon OK
    JAMA Neurol; 2015 Jul; 72(7):764-72. PubMed ID: 26010803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effects of clopidogrel dose adjustment (75 mg/d vs 150 mg/d) after carotid stenting.
    González A; Moniche F; Cayuela A; Gonzalez-Marcos JR; Mayol A; Montaner J
    J Vasc Surg; 2014 Aug; 60(2):428-35. PubMed ID: 24629989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.
    Adeeb N; Griessenauer CJ; Foreman PM; Moore JM; Shallwani H; Motiei-Langroudi R; Alturki A; Siddiqui AH; Levy EI; Harrigan MR; Ogilvy CS; Thomas AJ
    Stroke; 2017 May; 48(5):1322-1330. PubMed ID: 28411263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.
    Reed GW; Cannon CP; Waalen J; Teirstein PS; Tanguay JF; Berger PB; Angiolillo DJ; Price MJ
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):190-198. PubMed ID: 26909669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
    Nakagawa I; Park HS; Yokoyama S; Wada T; Hironaka Y; Motoyama Y; Takayama K; Kichikawa K; Nakase H
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):163-71. PubMed ID: 26493334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS study.
    Nakamura M; Isshiki T; Kimura T; Ogawa H; Yokoi H; Nanto S; Takayama M; Kitagawa K; Ikeda Y; Saito S
    Int J Cardiol; 2015 Mar; 182():541-8. PubMed ID: 25679803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel.
    Choi HH; Lee JJ; Cho YD; Han MH; Cho WS; Kim JE; An SJ; Mun JH; Yoo DH; Kang HS
    Neurosurgery; 2018 Nov; 83(5):981-988. PubMed ID: 29301051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
    Adeeb N; Gupta R; Schneider AM; Leadon M; Enriquez A; Griessenauer CJ; Salem M; Alturki A; Schmalz P; Ogilvy CS; Thomas AJ; Moore JM
    World Neurosurg; 2018 May; 113():e146-e152. PubMed ID: 29425984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching acute coronary syndrome patients from prasugrel to clopidogrel.
    Kerneis M; Silvain J; Abtan J; Cayla G; O'Connor SA; Barthélémy O; Vignalou JB; Beygui F; Brugier D; Martin R; Collet JP; Montalescot G
    JACC Cardiovasc Interv; 2013 Feb; 6(2):158-65. PubMed ID: 23428007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.
    Sedat J; Chau Y; Gaudart J; Sachet M; Beuil S; Lonjon M
    Interv Neuroradiol; 2017 Feb; 23(1):52-59. PubMed ID: 27760885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in Japanese patients with stable coronary artery disease.
    Nishi T; Ariyoshi N; Nakayama T; Fujimoto Y; Sugimoto K; Takahara M; Wakabayashi S; Koshizaka M; Hanaoka H; Kobayashi Y
    Circ J; 2015; 79(11):2439-44. PubMed ID: 26310876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of initial clinical presentation on clopidogrel low response.
    Landel JB; Bauters A; Delhaye C; Bonello L; Sudre A; Susen S; Bauters C; Lablanche JM; Lemesle G
    Arch Cardiovasc Dis; 2013 Nov; 106(11):593-600. PubMed ID: 24070598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acenocoumarol on the antiplatelet effect of clopidogrel.
    Dewilde WJ; Janssen PW; Bergmeijer TO; Kelder JC; Hackeng CM; ten Berg JM
    Thromb Haemost; 2015 Oct; 114(4):708-16. PubMed ID: 26177793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study.
    Saucedo JF; Angiolillo DJ; DeRaad R; Frelinger AL; Gurbel PA; Costigan TM; Jakubowski JA; Ojeh CK; Duvvuru S; Effron MB;
    Thromb Haemost; 2013 Feb; 109(2):347-55. PubMed ID: 23223867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting.
    González A; Moniche F; Cayuela A; García-Lozano JR; Torrecillas F; Escudero-Martínez I; Gonzalez-Marcos JR; Mayol A; Montaner J
    Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):175-86. PubMed ID: 26526111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Postprocedural Infarction and Antiplatelet Drug Resistance after Coiling for Unruptured Intracranial Aneurysms.
    Kim MS; Jo KI; Yeon JY; Kim JS; Kim KH; Jeon P; Hong SC
    AJNR Am J Neuroradiol; 2016 Jun; 37(6):1099-105. PubMed ID: 27056423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.